Immunofluorescence staining was performed after 7 days of drug treatment to investigate tissue integrity and presence of cell-specific markers. Membranes were excised from biochips and cells were fixed with
ROTIHistofix 4% (Carl Roth) for 10 min at RT. Permeabilization and blocking was performed by adding PBS (Lonza) containing 0.1% saponin (Carl Roth) and 3%
normal donkey serum (Abcam, Cambridge, UK) for 30 min at RT. The membrane was subsequently divided with scissors to independently stain the vascular and hepatic cell layers with the primary antibody solution. Primary antibodies ASGPR1 (BD Biosciences, Heidelberg, Germany),
CYP3A4 (Sigma-Aldrich), α-GST (BIOZOL, Eching, Germany), CD32b (BIOZOL) and
CD206 (Abcam) were incubated at 4 °C overnight. Membranes were washed with PBS/0.1% saponin and incubated with secondary antibodies
DAPI (Thermo Fisher Scientific),
donkey-anti-mouse-AF647 (Thermo Fisher Scientific),
donkey-anti-rabbit-Cy3 (Jackson ImmunoResearch, Cambridgeshire, UK) and
donkey-anti-goat-AF488 (Thermo Fisher Scientific) for 1 h at RT. Stained membranes were washed twice with PBS/0.1% saponin, once with PBS and lastly with
AQUA AD iniectabilia (B. Braun, Melsungen, Germany). Samples were embedded in
fluorescent mounting medium (Agilent Technologies, Waldbronn, Germany).
Kaden T., Graf K., Rennert K., Li R., Mosig A.S, & Raasch M. (2023). Evaluation of drug-induced liver toxicity of trovafloxacin and levofloxacin in a human microphysiological liver model. Scientific Reports, 13, 13338.